Avadel Pharmaceuticals PLC (STU:AWK)
€ 10 0.15 (1.52%) Market Cap: 949.15 Mil Enterprise Value: 888.38 Mil PE Ratio: 0 PB Ratio: 13.69 GF Score: 42/100

Q3 2022 Avadel Pharmaceuticals PLC Earnings Call Transcript

Nov 09, 2022 / 01:00PM GMT
Release Date Price: €5.85 (-4.10%)
Operator

Good morning. My name is Rob, and I will be your conference operator today. At this time, I would like to welcome everyone to the Avadel Pharmaceuticals Third Quarter 2022 Earnings Conference Call. (Operator Instructions) Thank you. [Austin Murta] from Avadel Investor Relations, you may begin your conference.

Unidentified Company Representative

Good morning and thank you for joining us on our conference call to discuss third quarter 2022 earnings. As a reminder, before we begin, the following presentation includes several matters that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that could cause the actual results to differ materially from those contemplated in such forward-looking statements. These risks include risks that products in the development stage may not achieve scientific objectives or milestones or meet stringent regulatory requirements, uncertainties regarding market entry and acceptance of products, and the impact of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot